PAVmed (PAVM) Share-based Compensation (QoQ) (2016 - 2025)
PAVmed (PAVM) Share-based Compensation (QoQ) (2016 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - |
| 10 | PAVmed | 9.85 Mn | -3.35 Mn | -4,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -38.13% |
| Sep 30, 2025 | 131.48% |
| Jun 30, 2025 | -32.78% |
| Mar 31, 2025 | -67.12% |
| Jun 30, 2024 | 103.85% |
| Mar 31, 2024 | -5.56% |
| Dec 31, 2023 | -55.95% |
| Sep 30, 2023 | 105.96% |
| Jun 30, 2023 | -9.09% |
| Mar 31, 2023 | 113.45% |
| Dec 31, 2022 | -287.17% |
| Sep 30, 2022 | 228.78% |
| Jun 30, 2022 | 13.47% |
| Mar 31, 2022 | 124.47% |
| Dec 31, 2021 | -230.80% |
| Sep 30, 2021 | -23.31% |
| Jun 30, 2021 | 724.56% |
| Mar 31, 2021 | 10.70% |
| Dec 31, 2020 | -2.73% |
| Sep 30, 2020 | 10.78% |